This application proposes continued funding of the Harvard University Center for AIDS Research (HU CFAR). HU CFAR is the umbrella organization for AIDS research at Harvard, operating out of the Provost's Office. It represents each of the Harvard affiliated schools as well as the affiliated hospitals, including Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Massachusetts General Hospital, Brigham & Women's Hospital. In addition, it includes the Lemuel Shattuck Hospital and Fenway Health, extending its reach to additional clinical populations and translational research sites outside Harvard. HU CFAR builds collaborations and provides infrastructure support to coordinate and promote emerging opportunities in basic, clinical, behavioral, and translational HIV research. Research emphasis among investigators includes studies of molecular virology, pathogenesis, host immune responses, epidemiology, treatment, vaccines and prevention. CFAR also oversees 3 Scientific Programs (Epidemiology and Implementation Science, International, and HIV Vaccines) as well as 3 Scientific Working Groups (HIV Eradication, TB-HIV Co-infection and Health Equity). Six Core facilities have also been identified for HU CFAR support: Clinical, Biostatistics and Bioinformatics, Humanized Mouse, Advanced Technologies, Behavioral and Social Sciences and Biosafety Level 3. In addition, an Administrative Core will provide strategic planning and fiscal oversight, and a Developmental Core will support innovative pilot projects related to the goals of the scientific programs and scientific working groups. Undertaking the following specific aims, the HU CFAR will continue to expand, promote, and facilitate collaborative, multidisciplinary activities in AID research among CFAR members as the Harvard University model for collaborative inter-institutional interactions:
Aim 1 : to facilitate and expand synergistic multidisciplinary collaborations among the diverse and highly successful HU-affiliated HIV/AIDS researchers and their trainees, Aim 2; to promote new interactions and support innovative research initiatives capable of more effectively addressing key HIV/AIDS related research questions aimed at bringing an end to the epidemic, Aim 3: to attract, engage, support and mentor the next generation of early career scientists into HIV/AIDS research.

Public Health Relevance

The HU CFAR is a comprehensive Center providing the infrastructure to integrate Harvard University's multidisciplinary AIDS-related clinical and basic research programs. This provides a unique platform to maximize the contribution to public health by Harvard's HIV/AIDS investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI060354-13
Application #
9111787
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Namkung, Ann S
Project Start
2004-07-01
Project End
2019-07-31
Budget Start
2016-08-01
Budget End
2017-07-31
Support Year
13
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
Organized Research Units
DUNS #
082359691
City
Cambridge
State
MA
Country
United States
Zip Code
Kirtane, Ameya R; Abouzid, Omar; Minahan, Daniel et al. (2018) Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy. Nat Commun 9:2
Mayer, Kenneth H; Chan, Philip A; R Patel, Rupa et al. (2018) Evolving Models and Ongoing Challenges for HIV Preexposure Prophylaxis Implementation in the United States. J Acquir Immune Defic Syndr 77:119-127
Calabrese, Sarah K; Earnshaw, Valerie A; Krakower, Douglas S et al. (2018) A Closer Look at Racism and Heterosexism in Medical Students' Clinical Decision-Making Related to HIV Pre-Exposure Prophylaxis (PrEP): Implications for PrEP Education. AIDS Behav 22:1122-1138
Richterman, Aaron; Cheung, Hoi Ching; Meiselbach, Mark K et al. (2018) Risk Factors for Self-Reported Cholera Within HIV-Affected Households in Rural Haiti. Open Forum Infect Dis 5:ofy127
Lodi, Sara; Günthard, Huldrych F; Dunn, David et al. (2018) Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance. AIDS 32:327-335
Luong Nguyen, Liem B; Yazdanpanah, Yazdan; Maman, David et al. (2018) Voluntary Community Human Immunodeficiency Virus Testing, Linkage, and Retention in Care Interventions in Kenya: Modeling the Clinical Impact and Cost-effectiveness. Clin Infect Dis 67:719-726
Gholizadeh, Shadi; Rooney, Benjamin M; Merz, Erin L et al. (2018) Body Image and Condomless Anal Sex Among Sexual Minority Men Living with HIV. AIDS Behav 22:658-662
Howe, Chanelle J; Dulin-Keita, Akilah; Cole, Stephen R et al. (2018) Evaluating the Population Impact on Racial/Ethnic Disparities in HIV in Adulthood of Intervening on Specific Targets: A Conceptual and Methodological Framework. Am J Epidemiol 187:316-325
Andersen, Lena S; Magidson, Jessica F; O'Cleirigh, Conall et al. (2018) A pilot study of a nurse-delivered cognitive behavioral therapy intervention (Ziphamandla) for adherence and depression in HIV in South Africa. J Health Psychol 23:776-787
North, Crystal M; Allen, Joseph G; Okello, Samson et al. (2018) HIV Infection, Pulmonary Tuberculosis, and COPD in Rural Uganda: A Cross-Sectional Study. Lung 196:49-57

Showing the most recent 10 out of 1030 publications